Location History:
- Svedala, SE (2020)
- Swedala, SE (2018 - 2023)
Company Filing History:
4 out of 5 
1 out of 56 
Years Active: 2018-2023
Title: The Innovative Contributions of Madeleine Dahlback
Introduction
Madeleine Dahlback is a prominent inventor based in Swedala, Sweden, who has made significant contributions in the field of biomedical research. With a total of four patents to her name, she is recognized for her innovative approaches in the treatment of conditions related to chondroitin sulfate glycans.
Latest Patents
Among her latest innovations is the patent focusing on "Targeting of chondroitin sulfate glycans." This invention encompasses functional binding fragments, which include minimal binding fragments of VAR2CSA, and the associated antibodies. It also covers nucleic acids encoding such fragments and methods for their production. This invention is particularly valuable in targeting conditions that involve inappropriate expression of chondroitin sulfate A (CSA).
Another notable patent by Dahlback is the "VAR2CSA-drug conjugates." This patent reveals VAR2CSA-drug conjugates that possess biological activity along with methods for their preparation and use. Furthermore, it discusses pharmaceutical compositions that include these conjugates, expanding the avenues for potential therapeutic applications.
Career Highlights
Throughout her career, Madeleine Dahlback has worked at notable companies such as Var2 Pharmaceuticals Aps and Zymeworks Inc. Her work at these organizations has allowed her to apply her innovative ideas in developing real-world applications for her inventions.
Collaborations
Dahlback has had the opportunity to collaborate with esteemed professionals, including Mads Daugaard and Ali Salanti. These partnerships have not only enriched her work but have also propelled advancements in the field through shared knowledge and expertise.
Conclusion
Madeleine Dahlback continues to make remarkable strides in her field, with her innovative patents addressing important health issues. Her work stands as a testament to the impact that dedicated inventors can have on advancing medical science and improving therapeutic strategies.